BioLineRx Ltd. (BLRX) stock
BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.15+0.03 (+2.68%)
Close on Nov 18, 2026Market cap $5.00MP/E –Yield –
BioLineRx operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$8.07M. The highest annual figure on record is -$8.07M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.07M | – |
| FY2024 | Dec 31, 2024 | -$43.87M | – |
| FY2023 | Dec 31, 2023 | -$22.61M | – |
| FY2022 | Dec 31, 2022 | -$26.24M | – |
| FY2021 | Dec 31, 2021 | -$23.57M | – |
| FY2020 | Dec 31, 2020 | -$23.21M | – |
| FY2019 | Dec 31, 2019 | -$22.67M | – |
| FY2018 | Dec 31, 2018 | -$24.19M | – |
| FY2017 | Dec 31, 2017 | -$20.55M | – |
| FY2016 | Dec 31, 2016 | -$14.51M | – |
| FY2015 | Dec 31, 2015 | -$14.17M | – |
See a number that looks wrong?